-
Lonza Prices EUR 500 Million Straight Bond with a 3.875% Coupon
Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a EUR 500 million Straight Bond. The Eurobond marks Lonza’s first drawdown under its newly established EMTN program. The bond has a maturity of 10 years and an annual coupon of 3.875%. The issuer is Lonza Finance International NV and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the Luxembourg Stock Exchange (Regulated Market). The proceeds of the bonds will be used for refinancing and general corporate purposes. Lonza’s issuer rating is currently BBB+ (S&P Global Ratings) with a stable outlook. A…
-
Q1 2023 Qualitative Update: Business Performance In Line With Full-Year Trajectory
Robust commercial demand, with softer early-stage demand due to biotech funding constraints Growth project portfolio progressing in line with plan Outlook 2023 reiterated, with high single-digit CER sales growth and CORE EBITDA margin of 30 to 31% In its quarterly qualitative update, Lonza reported Q1 performance in line with the trajectory for 2023. In Biologics, there was good momentum across the division, with sustained customer demand for commercial supply and softer demand for early stage services. The Small Molecules division delivered a solid performance. In Cell & Gene, biotech funding constraints impacted demand for pre-clinical and Phase 1 services. Finally, the performance of the Capsules & Health Ingredients division was impacted by the softer demand…
-
Lonza Announces Results of the 2023 Annual General Meeting
Shareholders re-elected all existing members of the Board of Directors Albert M. Baehny was re-elected as Chairman of the Board of Directors A dividend of CHF 3.50 per share will be paid out starting from 11 May 2023 Attending and represented shareholders collectively held a total of 46,482,431 shares, representing 62.42% of the share capital Shareholders approved the amendment of Lonza’s Articles of Association following the revision of the Swiss Company Law (Aktienrecht) KPMG re-elected as auditors for financial year 2023, Deloitte elected as auditors for financial year 2024 Today, Lonza Group Ltd hosted its Annual General Meeting (AGM), led by the Chairman of the Board of Directors, Albert M.…
-
Lonza Increases Straight Bond by CHF 150 Million
Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the increase of the Straight Bond issued on 8 February 2023 by CHF 150 million, in line with its financing plan for 2023. The increment has the same maturity (6.5 years) and coupon (2.100%) as the initial issuance. The issuer is Lonza Swiss Finance Ltd, Basel, and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the SIX Swiss Exchange. The proceeds of the bonds will be used for refinancing and general corporate purposes. Key Data Issue Size 6.5-Year Bond: CHF 150 million Expected Payment Date:…
-
Lonza Launches Share Buyback Program of up to CHF 2 Billion
On 3 April 2023, Lonza will launch a share buyback program of up to CHF 2 billion, as announced on 25 January 2023. Enabled by Lonza’s strong balance sheet and positive outlook, the share buyback program aims to return excess capital to shareholders without impacting the company’s capability to invest in organic growth and bolt-on M&A. At the same time, Lonza remains committed to maintaining its strong investment grade rating. The volume of monthly share buybacks will depend on market conditions. The registered shares of Lonza Group Ltd. will be repurchased via a second trading line on the SIX Swiss Exchange for the purpose of a capital reduction. Please visit…
-
Lonza Publishes Invitation to the 2023 Annual General Meeting and 2022 Annual and Sustainability Reports
Annual General Meeting to take place on 5 May 2023 at the Congress Center in Basel, Switzerland Albert M. Baehny proposed for re-election as Chairman of the Board of Directors, all current Board Members proposed for re-election KPMG proposed for re-election as auditors for the financial year 2023, with Deloitte Ltd, Zurich (CH) proposed for election for the financial year 2024 Amendment of Lonza’s Articles of Association following the revision of the Swiss Company Law (Aktienrecht) Proposed dividend increase of 17% to CHF 3.50 per share 2022 Annual and Sustainability Reports published Lonza today announced the publication of its 2022 Annual and Sustainability Reports, as well as its invitation…
-
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates The Visp (CH) investment includes two manufacturing suites and supporting infrastructure Additional manufacturing suites complement recent investments in Visp (CH) across small molecules and biologics development and manufacturing, including drug product Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, announced today that a planned expansion of its bioconjugation facility in Visp (CH) is complete. The expansion includes two manufacturing suites and supporting infrastructure. It will support an extended customer portfolio, including companies entering clinical development. The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and…
-
Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon
Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a CHF 300 million straight-bond issue in line with its financing plan for 2023. The bond has a maturity of 6.5 years and an annual coupon of 2.100%. The issuer is Lonza Swiss Finance Ltd, Basel, and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the SIX Swiss Exchange. The proceeds of the bonds will be used for refinancing and general corporate purposes. Key Data Issue Size 6.5-Year Bond: CHF 300 million Expected Payment Date: 22 February 2023 Maturity: 12 September 2029…
-
Lonza Delivers Strong 2022 Performance with 15.1% CER Sales Growth and 32.1% CORE EBITDA Margin
In 2022, Lonza delivered CHF 6.2 billion sales and 15.1%1 CER sales growth CHF 2.0 billion CORE EBITDA resulted in a margin of 32.1% Growth investment continues as 2022 CAPEX reached 30% of sales Group Outlook 2023: high single-digit CER sales growth and CORE EBITDA margin of 30 to 31% Mid-Term Guidance 2024 confirmed Proposed dividend increase of 17% to CHF 3.50 per share Share buyback program of up to CHF 2 billion announced, starting in 2023 Lonza has reported sales of CHF 6.2 billion, sales growth of 15.0% AER2 (15.1%1 CER), and CHF 2.0 billion CORE EBITDA, resulting in a margin of 32.1%. These robust financial results are driven by strong…
